Report Code: 12481 | Available Format: PDF | Pages: 235
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Analysis Period
1.4 Market Data Reporting Unit
1.4.1 Value
1.5 Market Size Breakdown by Segment
1.5.1 Market Segmentation by Type
1.5.2 Market Segmentation by Primary Package Type
1.5.3 Market Segmentation by Region
1.6 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.1.3 P&S Intelligence Database
2.2 Primary Research
2.2.1 Breakdown of Primary Research, by Region
2.2.2 Breakdown of Primary Research, by Industry Participant
2.2.3 Breakdown of Primary Research, by Designation
2.2.4 Breakdown of Primary Research, by Company Type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
2.6 Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
5.1 Biologics CDMO Market
5.2 Pharmaceutical Contract Packaging Market
5.3 Pharmaceutical Packaging Materials Market
5.4 Biologics Market
Chapter 6. Definition of Market Segments
6.1 By Type
6.1.1 Boxes
6.1.2 Cartons
6.1.3 Others
6.2 By Primary Package Type
6.2.1 Ampoules
6.2.2 Blister Packs
6.2.3 Bottles
6.2.4 Cartridges
6.2.5 Syringes and Vials
6.2.6 Prefilled Syringes
6.2.7 Others
Chapter 7. Industry Outlook
7.1 Market Dynamics
7.1.1 Trends
7.1.1.1 Increasing number of mergers & acquisitions and partnerships
7.1.1.2 Geographical expansions
7.1.2 Drivers
7.1.2.1 Shift in preference toward CDMOs
7.1.2.2 Growing pipeline of biologics
7.1.2.3 Companies involve in partnerships with biologics CDMOs to introduce novel products
7.1.2.4 Increasing prevalence of chronic diseases
7.1.3 Impact Analysis of Drivers on Market Forecast
7.1.4 Restraints
7.1.4.1 Increasing costs of packaging
7.1.5 Impact Analysis of Restraints on Market Forecast
7.2 Impact of COVID-19
7.3 Porter’s Five Forces Analysis
7.3.1 Bargaining Power of Buyers
7.3.2 Bargaining Power of Suppliers
7.3.3 Intensity of Rivalry
7.3.4 Threat of New Entrants
7.3.5 Threat of Substitutes
Chapter 8. Global Market Size and Forecast
8.1 Overview
8.2 Market Revenue, by Type (2019–2030)
8.3 Market Revenue, by Primary Package Type (2019–2030)
8.4 Market Revenue, by Region (2019–2030)
Chapter 9. North America Market Size and Forecast
9.1 Overview
9.2 Market Revenue, by Type (2019–2030)
9.3 Market Revenue, by Primary Package Type (2019–2030)
9.4 Market Revenue, by Country (2019–2030)
Chapter 10. Europe Market Size and Forecast
10.1 Overview
10.2 Market Revenue, by Type (2019–2030)
10.3 Market Revenue, by Primary Package Type (2019–2030)
10.4 Market Revenue, by Country (2019–2030)
Chapter 11. APAC Market Size and Forecast
11.1 Overview
11.2 Market Revenue, by Type (2019–2030)
11.3 Market Revenue, by Primary Package Type (2019–2030)
11.4 Market Revenue, by Country (2019–2030)
Chapter 12. LATAM Market Size and Forecast
12.1 Overview
12.2 Market Revenue, by Type (2019–2030)
12.3 Market Revenue, by Primary Package Type (2019–2030)
12.4 Market Revenue, by Country (2019–2030)
Chapter 13. MEA Market Size and Forecast
13.1 Overview
13.2 Market Revenue, by Type (2019–2030)
13.3 Market Revenue, by Primary Package Type (2019–2030)
13.4 Market Revenue, by Country (2019–2030)
Chapter 14. Biologics CDMO Secondary Packaging Equipment Market
14.1 Overview
14.2 Market Revenue, by Type (2019–2030)
14.3 Market Revenue, by Region (2019–2030)
14.4 List of Top Biologics CDMO and Their Service Offerings (Including Packaging)
14.5 List of Top Secondary Packaging Equipment Manufacturers and Their Offerings
Chapter 15. Sterile Products Packaging Equipment Market
15.1 Overview
15.2 Market Revenue, by Type (2019–2030)
15.2.1 Sterile Products Primary Packaging Equipment Market Revenue, by Type (2019–2030)
15.2.2 Sterile Products Secondary Packaging Equipment Market Revenue, by Type (2019–2030)
15.2.3 Sterile Products End-of-Line Packaging Equipment Market Revenue, by Type (2019–2030)
15.3 Market Revenue, by Region (2019–2030)
15.4 List of Top Sterile Products Packaging Equipment Manufacturers and Their Offerings
Chapter 16. Competitive Landscape
16.1 List of Market Players and Their Services Mapping
16.2 Strategic Developments in the Market
16.2.1 Mergers and Acquisitions
16.2.2 Service Launch
16.2.3 Partnerships
16.2.4 Client Win
16.2.5 Other Developments
Chapter 17. Company Profiles
17.1 Catalent Inc.
17.1.1 Business Overview
17.1.2 Product and Service Offerings
17.1.3 Key Financial Summary
17.2 Rentschler Biopharma SE
17.2.1 Business Overview
17.2.2 Product and Service Offerings
17.3 Emergent BioSolutions Inc.
17.3.1 Business Overview
17.3.2 Product and Service Offerings
17.3.3 Key Financial Summary
17.4 WuXi Biologics (Cayman) Inc.
17.4.1 Business Overview
17.4.2 Product and Service Offerings
17.4.3 Key Financial Summary
17.5 Samsung Biologics Co. Ltd.
17.5.1 Business Overview
17.5.2 Product and Service Offerings
17.5.3 Key Financial Summary
17.6 Lonza Group Ltd.
17.6.1 Business Overview
17.6.2 Product and Service Offerings
17.6.3 Key Financial Summary
17.7 Pfizer Inc.
17.7.1 Business Overview
17.7.2 Product and Service Offerings
17.7.3 Key Financial Summary
17.8 FUJIFILM Diosynth Biotechnologies U.S.A. Inc.
17.8.1 Business Overview
17.8.2 Product and Service Offerings
17.9 Thermo Fisher Scientific Inc.
17.9.1 Business Overview
17.9.2 Product and Service Offerings
17.9.3 Key Financial Summary
17.10 Eurofins Scientific
17.10.1 Business Overview
17.10.2 Product and Service Offerings
17.10.3 Key Financial Summary
17.11 Oncomed Manufacturing a.s.
17.11.1 Business Overview
17.11.2 Product and Service Offerings
17.12 IDT Biologika GmbH
17.12.1 Business Overview
17.12.2 Product and Service Offerings
17.13 Recipharm AB
17.13.1 Business Overview
17.13.2 Product and Service Offerings
17.14 Delpharm Holding
17.14.1 Business Overview
17.14.2 Product and Service Offerings
17.15 Siegfried Holding AG
17.15.1 Business Overview
17.15.2 Product and Service Offerings
17.15.3 Key Financial Summary
17.16 PCI Pharma Services
17.16.1 Business Overview
17.16.2 Product and Service Offerings
17.17 Fareva Group
17.17.1 Business Overview
17.17.2 Product and Service Offerings
17.18 CMIC Holdings Co. Ltd.
17.18.1 Business Overview
17.18.2 Product and Service Offerings
17.18.3 Key Financial Summary
17.19 Aphena Pharma Solutions
17.19.1 Business Overview
17.19.2 Product and Service Offerings
17.20 HALIX B.V.
17.20.1 Business Overview
17.20.2 Product and Service Offerings
17.21 TOYOBO CO. LTD.
17.21.1 Business Overview
17.21.2 Product and Service Offerings
17.21.3 Key Financial Summary
17.22 Sharp Services LLC
17.22.1 Business Overview
17.22.2 Product and Service Offerings
17.23 Almac Group Limited
17.23.1 Business Overview
17.23.2 Product and Service Offerings
17.24 AbbVie Inc.
17.24.1 Business Overview
17.24.2 Product and Service Offerings
17.24.3 Key Financial Summary
Chapter 18. Appendix
18.1 Sources and References
18.2 Related Reports
LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 RECENT ACQUISITIONS
TABLE 5 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2019–2024)
TABLE 6 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2025–2030)
TABLE 7 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 8 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2019–2024)
TABLE 9 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2025–2030)
TABLE 10 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2027–2030)
TABLE 11 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY REGION, $M (2019–2024)
TABLE 12 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY REGION, $M (2025–2030)
TABLE 13 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY REGION, $M (2027–2030)
TABLE 14 NORTH AMERICA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2019–2024)
TABLE 15 NORTH AMERICA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2025–2030)
TABLE 16 NORTH AMERICA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 17 NORTH AMERICA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2019–2024)
TABLE 18 NORTH AMERICA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2025–2030)
TABLE 19 NORTH AMERICA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2027–2030)
TABLE 20 NORTH AMERICA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2019–2024)
TABLE 21 NORTH AMERICA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2025–2030)
TABLE 22 NORTH AMERICA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 23 EUROPE BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2019–2024)
TABLE 24 EUROPE BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2025–2030)
TABLE 25 EUROPE BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 26 EUROPE BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2019–2024)
TABLE 27 EUROPE BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2025–2030)
TABLE 28 EUROPE BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2027–2030)
TABLE 29 EUROPE BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2019–2024)
TABLE 30 EUROPE BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2025–2030)
TABLE 31 EUROPE BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 32 APAC BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2019–2024)
TABLE 33 APAC BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2025–2030)
TABLE 34 APAC BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 35 APAC BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2019–2024)
TABLE 36 APAC BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2025–2030)
TABLE 37 APAC BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2027–2030)
TABLE 38 APAC BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2019–2024)
TABLE 39 APAC BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2025–2030)
TABLE 40 APAC BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 41 LATAM BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2019–2024)
TABLE 42 LATAM BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2025–2030)
TABLE 43 LATAM BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 44 LATAM BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2019–2024)
TABLE 45 LATAM BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2025–2030)
TABLE 46 LATAM BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2027–2030)
TABLE 47 LATAM BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2019–2024)
TABLE 48 LATAM BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2025–2030)
TABLE 49 LATAM BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 50 MEA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2019–2024)
TABLE 51 MEA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2025–2030)
TABLE 52 MEA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 53 MEA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2019–2024)
TABLE 54 MEA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2025–2030)
TABLE 55 MEA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2027–2030)
TABLE 56 MEA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2019–2024)
TABLE 57 MEA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2025–2030)
TABLE 58 MEA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 59 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2019–2024)
TABLE 60 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2025–2030)
TABLE 61 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 62 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING EQUIPMENT MARKET REVENUE, BY REGION, $M (2019–2024)
TABLE 63 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING EQUIPMENT MARKET REVENUE, BY REGION, $M (2025–2030)
TABLE 64 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING EQUIPMENT MARKET REVENUE, BY REGION, $M (2027–2030)
TABLE 65 LIST OF TOP BIOLOGICS CDMO AND THEIR SERVICE OFFERINGS (INCLUDING PACKAGING)
TABLE 66 LIST OF TOP SECONDARY PACKAGING EQUIPMENT MANUFACTURERS AND THEIR OFFERINGS
TABLE 67 GLOBAL STERILE PRODUCTS PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2019–2024)
TABLE 68 GLOBAL STERILE PRODUCTS PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2025–2030)
TABLE 69 GLOBAL STERILE PRODUCTS PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 70 GLOBAL STERILE PRODUCTS PRIMARY PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2019–2024)
TABLE 71 GLOBAL STERILE PRODUCTS PRIMARY PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2025–2030)
TABLE 72 GLOBAL STERILE PRODUCTS PRIMARY PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 73 GLOBAL STERILE PRODUCTS SECONDARY PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2019–2024)
TABLE 74 GLOBAL STERILE PRODUCTS SECONDARY PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2025–2030)
TABLE 75 GLOBAL STERILE PRODUCTS SECONDARY PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 76 GLOBAL STERILE PRODUCTS END-OF-LINE PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2019–2024)
TABLE 77 GLOBAL STERILE PRODUCTS END-OF-LINE PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2025–2030)
TABLE 78 GLOBAL STERILE PRODUCTS END-OF-LINE PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2027–2030)
TABLE 79 GLOBAL STERILE PRODUCTS PACKAGING EQUIPMENT MARKET REVENUE, BY REGION, $M (2019–2024)
TABLE 80 GLOBAL STERILE PRODUCTS PACKAGING EQUIPMENT MARKET REVENUE, BY REGION, $M (2025–2030)
TABLE 81 GLOBAL STERILE PRODUCTS PACKAGING EQUIPMENT MARKET REVENUE, BY REGION, $M (2027–2030)
TABLE 82 LIST OF TOP STERILE PRODUCTS PACKAGING EQUIPMENT MANUFACTURERS AND THEIR OFFERINGS
TABLE 83 SERVICE MAPPING - BY PRIMARY PACKAGE TYPE
TABLE 84 SERVICE MAPPING - BY TYPE
TABLE 85 CATALENT INC. – AT A GLANCE
TABLE 86 CATALENT INC. – KEY FINANCIAL SUMMARY
TABLE 87 RENTSCHLER BIOPHARMA SE – AT A GLANCE
TABLE 88 EMERGENT BIOSOLUTIONS INC. – AT A GLANCE
TABLE 89 EMERGENT BIOSOLUTIONS INC. – KEY FINANCIAL SUMMARY
TABLE 90 WUXI BIOLOGICS (CAYMAN) INC. – AT A GLANCE
TABLE 91 WUXI BIOLOGICS (CAYMAN) INC. – KEY FINANCIAL SUMMARY
TABLE 92 SAMSUNG BIOLOGICS CO. LTD. – AT A GLANCE
TABLE 93 SAMSUNG BIOLOGICS CO. LTD. – KEY FINANCIAL SUMMARY
TABLE 94 LONZA GROUP LTD. – AT A GLANCE
TABLE 95 LONZA GROUP LTD. – KEY FINANCIAL SUMMARY
TABLE 96 PFIZER INC. – AT A GLANCE
TABLE 97 PFIZER INC. – KEY FINANCIAL SUMMARY
TABLE 98 FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A. INC. – AT A GLANCE
TABLE 99 THERMO FISHER SCIENTIFIC INC. – AT A GLANCE
TABLE 100 THERMO FISHER SCIENTIFIC INC. – KEY FINANCIAL SUMMARY
TABLE 101 EUROFINS SCIENTIFIC – AT A GLANCE
TABLE 102 EUROFINS SCIENTIFIC – KEY FINANCIAL SUMMARY
TABLE 103 ONCOMED MANUFACTURING A.S. – AT A GLANCE
TABLE 104 IDT BIOLOGIKA GMBH – AT A GLANCE
TABLE 105 RECIPHARM AB – AT A GLANCE
TABLE 106 DELPHARM HOLDING – AT A GLANCE
TABLE 107 SIEGFRIED HOLDING AG – AT A GLANCE
TABLE 108 SIEGFRIED HOLDING AG – KEY FINANCIAL SUMMARY
TABLE 109 PCI PHARMA SERVICES – AT A GLANCE
TABLE 110 FAREVA GROUP – AT A GLANCE
TABLE 111 CMIC HOLDINGS CO. LTD. – AT A GLANCE
TABLE 112 CMIC HOLDINGS CO. LTD. – KEY FINANCIAL SUMMARY
TABLE 113 APHENA PHARMA SOLUTIONS – AT A GLANCE
TABLE 114 HALIX B.V. – AT A GLANCE
TABLE 115 TOYOBO CO. LTD. – AT A GLANCE
TABLE 116 TOYOBO CO. LTD. – KEY FINANCIAL SUMMARY
TABLE 117 SHARP SERVICES LLC – AT A GLANCE
TABLE 118 ALMAC GROUP LIMITED – AT A GLANCE
TABLE 119 ABBVIE INC. – AT A GLANCE
TABLE 120 ABBVIE INC. – KEY FINANCIAL SUMMARY
LIST OF FIGURES
FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT
FIG 2 RESEARCH METHODOLOGY
FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION
FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT
FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
FIG 6 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
FIG 7 DATA TRIANGULATION APPROACH
FIG 8 CURRENCY CONVERSION RATES FOR USD (2023)
FIG 9 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET SUMMARY
FIG 10 VOICE OF INDUSTRY EXPERTS/KOLS
FIG 11 GLOBAL BIOLOGICS CDMO MARKET SNAPSHOT
FIG 12 GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET REVENUE, $M (2019–2030)
FIG 13 GLOBAL PHARMACEUTICAL PACKAGING MATERIALS MARKET REVENUE, $M (2019–2030)
FIG 14 GLOBAL PHARMACEUTICAL PACKAGING MATERIALS MARKET REVENUE, BY TYPE, $M (2023)
FIG 15 GLOBAL BIOLOGICS MARKET, $B (2021 & 2025)
FIG 16 BARGAINING POWER OF BUYERS
FIG 17 BARGAINING POWER OF SUPPLIERS
FIG 18 INTENSITY OF RIVALRY
FIG 19 THREAT OF NEW ENTRANTS
FIG 20 THREAT OF SUBSTITUTES
FIG 21 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET SNAPSHOT
FIG 22 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2019–2030)
FIG 23 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2019–2030)
FIG 24 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY REGION, $M (2019–2030)
FIG 25 NORTH AMERICA BIOLOGICS CDMO SECONDARY PACKAGING MARKET SNAPSHOT
FIG 26 NORTH AMERICA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2019–2030)
FIG 27 NORTH AMERICA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2019–2030)
FIG 28 NORTH AMERICA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2019–2030)
FIG 29 EUROPE BIOLOGICS CDMO SECONDARY PACKAGING MARKET SNAPSHOT
FIG 30 EUROPE BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2019–2030)
FIG 31 EUROPE BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2019–2030)
FIG 32 EUROPE BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2019–2030)
FIG 33 APAC BIOLOGICS CDMO SECONDARY PACKAGING MARKET SNAPSHOT
FIG 34 APAC BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2019–2030)
FIG 35 APAC BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2019–2030)
FIG 36 APAC BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2019–2030)
FIG 37 LATAM BIOLOGICS CDMO SECONDARY PACKAGING MARKET SNAPSHOT
FIG 38 LATAM BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2019–2030)
FIG 39 LATAM BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2019–2030)
FIG 40 LATAM BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2019–2030)
FIG 41 MEA BIOLOGICS CDMO SECONDARY PACKAGING MARKET SNAPSHOT
FIG 42 MEA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY TYPE, $M (2019–2030)
FIG 43 MEA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY PRIMARY PACKAGE TYPE, $M (2019–2030)
FIG 44 MEA BIOLOGICS CDMO SECONDARY PACKAGING MARKET REVENUE, BY COUNTRY, $M (2019–2030)
FIG 45 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2019–2030)
FIG 46 GLOBAL BIOLOGICS CDMO SECONDARY PACKAGING EQUIPMENT MARKET REVENUE, BY REGION, $M (2019–2030)
FIG 47 GLOBAL STERILE PRODUCTS PACKAGING EQUIPMENT MARKET REVENUE, BY TYPE, $M (2019–2030)
FIG 48 GLOBAL STERILE PRODUCTS PACKAGING EQUIPMENT MARKET REVENUE, BY REGION, $M (2019–2030)
FIG 49 CATALENT INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 50 EMERGENT BIOSOLUTIONS INC. – REVENUE SPLIT BY SEGMENT (2023)
FIG 51 WUXI BIOLOGICS (CAYMAN) INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 52 SAMSUNG BIOLOGICS CO. LTD. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 54 PFIZER INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 57 SIEGFRIED HOLDING AG – REVENUE SPLIT BY PRODUCT GROUP (2023)
FIG 59 TOYOBO CO. LTD. – REVENUE SPLIT BY SEGMENT (2023)
FIG 60 ABBVIE INC. – REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2023)
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws